Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis

NCT02324972 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: AQX-1125
DRUG: Placebo

Sponsor

Aquinox Pharmaceuticals (Canada) Inc.

Collaborators

[object Object]